|
| Frequency | % |
Age (years) | Mean ± SD | 51.2 ± 9.9 (Range: 33 - 72 years) |
|
BMI | Mean ± SD | 28 ± 9.4 |
|
Residence | Urban | 13 | 39.3% |
| Rural | 20 | 60.6% |
Tumor Type | IDC | 33 | 100.0% |
Ductal carcinoma in situ (DCIS) | No | 20 | 60.6% |
Yes | 13 | 39.4% | |
Desmoplastic reaction | None | 13 | 39.4% |
Mild | 8 | 24.2% | |
Moderate | 7 | 21.2% | |
Marked | 5 | 15.2% | |
Lymph Nodes involvement | No | 12 | 36.4% |
Yes | 21 | 63.6% | |
Largest Tumor diameters | Mean (SD) | 4.0 (2.4) |
|
Tumor Stage | IA | 2 | 6.1% |
IIA | 7 | 21.2% | |
IIB | 8 | 24.2% | |
IIIA | 3 | 9.1% | |
IIIC | 2 | 6.1% | |
IV | 11 | 33.3% | |
Tumor Grade | I | 1 | 3.0% |
II | 31 | 93.9% | |
III | 1 | 3.0% | |
Estrogen Receptors (ER) | Negative | 10 | 30.3% |
Positive | 23 | 69.7% | |
Progesterone Receptors (PR) | Negative | 10 | 30.3% |
Positive | 23 | 69.7% |